Background: Rivaroxaban is currently used to prevent stroke in patients with atrial fibrillation. Measuring coagulation function may help clinicians to understand the effects of this drug and the associated risk of bleeding.Methods And Results: Rivaroxaban was given to 136 patients with non-valvular atrial fibrillation.